2017年雅思閲讀理解考試樣題輔導練習
光陰易逝,豈容我待,以下是小編為大家搜索整理的2017年雅思閲讀理解考試樣題輔導練習,希望能給大家帶來幫助!更多精彩內容請及時關注我們應屆畢業生考試網!
Why did a promising heart drug fail?
Doomed drug highlights complications of meddling with cholesterol.
1. The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels. But many researchers remain confident that drugs to boost levels of 'good' cholesterol are still one of the most promising means to combat spiralling heart disease.
2. Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib, a drug designed to raise heart-protective high-density lipoproteins (HDLs). In a trial of 15000 patients, a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone.
3. The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease. "There have been no red flags to my knowledge," says John Chapman, a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib. "This cancellation came as a complete shock."
4. Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs, which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body. Specifically, torcetrapib blocks a protein called cholesterol ester transfer protein (CETP), which normally transfers the cholesterol from high-density lipoproteins to low density, plaque-promoting ones. Statins, in contrast, mainly work by lowering the 'bad' low-density lipoproteins.
Under pressure
5. Researchers are now trying to work out why and how the drug backfired, something that will not become clear until the clinical details are released by Pfizer. One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients. It was thought that this mild problem would be offset by the heart benefits of the drug. But it is possible that it actually proved fatal in some patients who already suffered high blood pressure. If blood pressure is the explanation, it would actually be good news for drug developers because it suggests that the problems are specific to this compound. Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall.
6. But it is also possible that the whole idea of blocking CETP is flawed, says Moti Kashyap, who directs atherosclerosis research at the VA Medical Center in Long Beach, California. When HDLs excrete cholesterol in the liver, they actually rely on LDLs for part of this process. So inhibiting CETP, which prevents the transfer of cholesterol from HDL to LDL, might actually cause an abnormal and irreversible accumulation of cholesterol in the body. "You're blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway," says Kashyap.
Going up
7. Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients. But HDLs are complex and not entirely understood. One approved drug, called niacin, is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling. Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone. Scientists are also working on several other means to bump up high-density lipoproteins by, for example, introducing synthetic HDLs. "The only thing we know is dead in the water is torcetrapib, not the whole idea of raising HDL," says Michael Miller, director of preventive cardiology at the University of Maryland Medical Center, Baltimore.
(613 words nature)
Questions 1-7
This passage has 7 paragraphs 1-7.
Choose the correct heading for each paragraph from the list of headings below.
Write the correct number i-ix in boxes 1-7 on your answer sheet.
List of Headings
i. How does torcetrapib work?
ii. Contradictory result prior to the current trial
iii. One failure may possibly bring about future success
iv. The failure doesn’t lead to total loss of confidence
v. It is the right route to follow
vi. Why it’s stopped
vii. They may combine and theoretically produce ideal result
viii. What’s wrong with the drug
ix. It might be wrong at the first place
Example answer
Paragraph 1 iv
1. Paragraph 2
2. Paragraph 3
3. Paragraph 4
4. Paragraph 5
5. Paragraph 6
6. Paragraph 7
Questions 7-13
Match torcetrapib,HDLs,statin and CETP with their functions (Questions 8-13)..
Write the correct letter A, B, C or D in boxes 8-13 on your answer sheet.
NB You may use any letter more than once.
has been administered to over 10,000 subjects in a clinical trial.
could help rid human body of cholesterol.
archers are yet to find more about it.
10. It was used to reduce the level of cholesterol.
11. According to Kashyap, it might lead to unwanted result if it’s blocked.
12. It produced contradictory results in different trials.
13. It could inhibit LDLs.
List of choices
A. Torcetrapic
B. HDLS
C. Statin
D. CETP
Suggested Answers and Explanations1. vi
2. ii
3. vii 本段介紹了torcetrapib和statin的.治病原理,但是同時短語“in contrast”與之前第二段後半段的內容呼應,暗示了這兩種藥在理論上能相輔相成,是理想的搭配。第一個選項無法涵蓋整段意義,故選擇i是錯誤的。
4. iii 本段分析了可能導致torcetrapibl臨牀試驗失敗的原因,後半段指出如果以上推測正確,那麼未來的藥物可借鑑這個試驗,設法避免torcetrapib的缺陷,研製出有效的藥物。viii選項無法涵蓋後半段的意思。
5. ix 見首句。
6. v
7. A 見第二段。題目中administer一詞意為“用藥”,subject一詞為“實驗對象”之意。
8. B 見第四段“… to raise levels of HDLs, which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body.”即HDLs的作用最終是將choleserol清除出人體:“… for removal from the body”。
9. B 見第四段“But HDLs are complex and not entirely understood.”
10. C 見第二段“… plus a cholesterol-lowering statin”,即statin是可以降低cholesterol的。
11. D 見第六段“So inhibiting CETP, … might actually cause an abnormal and irreversible accumulation of cholesterol in the body.
12. A 見第三段。
13. C 見第四段“Statins, in contrast, mainly work by lowering the 'bad' low-density lipoproteins.”
-
雅思大作文Task2考官範文
認真研讀雅思範文可以幫助我們瞭解自己的不足,也可以提高我們的寫作水平。下面是小編分享的雅思英語作文範文,希望能對大家有所幫助!雅思作文範文【1】Shouldanimalsbeusedintestingnewdrugsandprocedures?ModelAnswer:Everyyear,millionsofanimalsundergopainfu...
-
2016年雅思考試詞彙量的要求
備考雅思考試的考生們,知道要掌握多少雅思詞彙量才有可能通過雅思考試嗎?下面yjbys網小編為大家整理提供2016年雅思考試詞彙量要求。祝考生們順利通過雅思考試!雅思詞彙水平是進行任何考試都必備的基礎能力。雅思6分詞彙量相當於大學英語四、六級的詞彙水平,但雅...
-
雅思考試經驗分享
雅思考試經驗分享雅思考試(IELTS),外文名InternationalEnglishLanguageTestingSystem,由劍橋大學考試委員會外語考試部、英國文化協會及IDP教育集團共同管理,是一種針英語能力,為打算到使用英語的國家學習、工作或定居的人們設置的英語水平考試。下面是小編收集的同...
-
雅思備考:如何鍛鍊英語思維表達
英語學習中,我們做了大量的閲讀,也學習寫作。閲讀時偏重理解。寫作時,偏重文章結構,應付考試有成套的句型,平時寫作文像漢英對譯。但實際中的語言五彩繽紛的。説出自然的英語最重要。NaturalEnglishisthepoint.要想做到説出natural英語,當你理解了英文句子是怎樣通...